Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people starting tirzepatide notice real changes in their energy levels, both up and down, as their body adjusts. Fatigue is one of the more commonly reported early experiences, usually tied to reduced calorie intake and the initial physiological shift rather than the medicine itself doing harm. Understanding why helps you get through the first few weeks with far less anxiety. Mounjaro is a prescription-only medicine, and a clinician reviews every patient before treatment begins — so the context here is education, not a substitute for that conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing to understand is that a dip in energy during the opening weeks of tirzepatide treatment is not unusual. Your appetite has fallen, your food intake has dropped, and your body is recalibrating — that takes fuel. The NHS medicines page for tirzepatide lists fatigue among the commonly reported side effects, particularly around dose increases.
Nausea and disrupted digestion also play a role. If your stomach is unsettled (especially in the days after a new injection) eating feels harder, and that can mean you're taking in less than your body actually needs to feel sharp. The result can look like tiredness but is really closer to under-fuelling.
It's worth noting that this phase tends to be at its most pronounced in the first four to eight weeks, and often improves as the GI side effects settle and eating patterns find a new rhythm. Most people report the fatigue softening before their third or fourth pen. That said, if tiredness feels severe or persistent, it belongs in a conversation with your prescriber rather than on a forum. If you want a closer look at why this happens and what you can do about it, our guide to having no energy on Mounjaro covers the causes and practical responses in detail.
Energy and sleep are tightly linked, and tirzepatide can affect both. Some patients report changes to their sleep in the early weeks, lighter sleep, vivid dreams, or waking earlier. Those disruptions feed directly into daytime tiredness in a way that can feel like the medicine is draining you, when the mechanism is more indirect.
There is also a positive side to this story. Obstructive sleep apnoea is one of the weight-related conditions that tirzepatide is licensed to help address, and as weight falls, some people find their sleep quality improves meaningfully over months. Reduced apnoea events, less snoring, and deeper sleep can translate into genuinely better morning energy, sometimes for the first time in years. The relationship between Mounjaro and sleep is worth reading about separately if this is a pattern you're noticing.
Practical note: if you take your injection in the evening and notice restless nights, shifting the injection day to the morning is something some patients discuss with their prescriber. Nothing here should be acted on without that conversation first.
The single most controllable factor in how your energy holds up on tirzepatide is what you eat within a reduced appetite. Protein matters most. When calorie intake falls sharply, the body can draw on lean muscle as well as fat, and muscle loss drags energy down more than fat loss does. Aiming to anchor meals around protein sources (eggs, fish, dairy, legumes) even when portions feel small is the advice most dietitians give alongside any GLP-1 medicine.
Hydration is underestimated. Nausea sometimes puts people off drinking enough, and mild dehydration is a fast route to a flat, foggy afternoon. Plain water, taken steadily rather than in large amounts at once, is usually easier to manage than anything carbonated.
Light activity (a 20-minute walk after lunch rather than a gym session) can help blood sugar and energy regulation without the recovery demand of intense exercise on a reduced intake. As weight falls and energy improves, intensity can build naturally. The NHS Live Well guidance on healthy weight covers the dietary side of this in accessible detail. For a fuller picture of how tirzepatide works as a medicine, the tirzepatide overview explains the dual GIP and GLP-1 mechanism clearly.
For some patients, energy becomes a reason to revisit their dose with their prescriber. Titrating faster than the body is ready for can leave someone feeling persistently flat. Titrating more slowly (staying at a lower dose for an extra month) is a legitimate clinical decision and one prescribers make regularly.
For others, the energy story genuinely turns positive. As BMI falls and metabolic load reduces, many people describe feeling more energetic at six months than they can remember being in years. That improvement is one of the reasons people describe treatment as life-changing, though experiences vary and clinical trials report averages, not individual outcomes. There is more on the dose-level picture and what each stage feels like at the Mounjaro levels guide.
If low energy is something you're experiencing right now and want to understand better before or during treatment, the guide to low energy on Mounjaro goes into more practical detail. And if you're looking at the cost side of private treatment, the Mounjaro price page explains what's included in a legitimate private prescription. When you're ready to speak to a prescriber about whether treatment suits you, check your eligibility through a free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.